Serina Therapeutics, Inc. (SER) stock
SERNYSEPharmaceutical PreparationsFiscal year ends December 31
$1.42+0.03 (+2.16%)
Close on Nov 16, 2026Market cap $36.07MP/E –Yield –
Serina Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Serina Therapeutics's total assets was $25.81M at Jun 30, 2026. For fiscal 2025 it was $6.95M, up 3.4% from the year before. The highest annual figure on record is $10.67M in fiscal 2018.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.95M | +3.4% |
| FY2024 | Dec 31, 2024 | $6.72M | -25.0% |
| FY2023 | Dec 31, 2023 | $8.97M | +176.7% |
| FY2022 | Dec 31, 2022 | $3.24M | +2.8% |
| FY2021 | Dec 31, 2021 | $3.15M | -19.6% |
| FY2020 | Dec 31, 2020 | $3.93M | -47.3% |
| FY2019 | Dec 31, 2019 | $7.44M | -30.3% |
| FY2018 | Dec 31, 2018 | $10.67M | +10.8% |
| FY2017 | Dec 31, 2017 | $9.63M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $25.81M | +188.7% |
| Q1 FY2026 | Mar 31, 2026 | $27.30M | +305.6% |
| Q4 FY2025 | Dec 31, 2025 | $6.95M | +3.4% |
| Q3 FY2025 | Sep 30, 2025 | $12.41M | +67.0% |
| Q2 FY2025 | Jun 30, 2025 | $8.94M | -16.5% |
| Q1 FY2025 | Mar 31, 2025 | $6.73M | -38.0% |
| Q4 FY2024 | Dec 31, 2024 | $6.72M | -25.0% |
| Q3 FY2024 | Sep 30, 2024 | $7.44M | -39.1% |
| Q2 FY2024 | Jun 30, 2024 | $10.71M | -12.8% |
| Q1 FY2024 | Mar 31, 2024 | $10.86M | -13.4% |
| Q4 FY2023 | Dec 31, 2023 | $8.97M | +176.7% |
| Q3 FY2023 | Sep 30, 2023 | $12.21M | +508.1% |
| Q2 FY2023 | Jun 30, 2023 | $12.28M | +376.0% |
| Q1 FY2023 | Mar 31, 2023 | $12.53M | +361.4% |
| Q4 FY2022 | Dec 31, 2022 | $3.24M | +2.8% |
| Q3 FY2022 | Sep 30, 2022 | $2.01M | -17.3% |
| Q2 FY2022 | Jun 30, 2022 | $2.58M | +1.5% |
| Q1 FY2022 | Mar 31, 2022 | $2.72M | -14.1% |
| Q4 FY2021 | Dec 31, 2021 | $3.15M | -19.6% |
| Q3 FY2021 | Sep 30, 2021 | $2.43M | -42.3% |
| Q2 FY2021 | Jun 30, 2021 | $2.54M | -46.6% |
| Q1 FY2021 | Mar 31, 2021 | $3.16M | -37.9% |
| Q4 FY2020 | Dec 31, 2020 | $3.93M | -47.3% |
| Q3 FY2020 | Sep 30, 2020 | $4.20M | -48.6% |
| Q2 FY2020 | Jun 30, 2020 | $4.76M | -53.6% |
| Q1 FY2020 | Mar 31, 2020 | $5.09M | -58.7% |
| Q4 FY2019 | Dec 31, 2019 | $7.44M | -30.3% |
| Q3 FY2019 | Sep 30, 2019 | $8.18M | -15.0% |
| Q2 FY2019 | Jun 30, 2019 | $10.26M | – |
| Q1 FY2019 | Mar 31, 2019 | $12.32M | – |
| Q4 FY2018 | Dec 31, 2018 | $10.67M | – |
| Q4 FY2017 | Dec 31, 2017 | $9.63M | – |
See a number that looks wrong?